Sava Infond D.O.O. Edwards Lifesciences Corp Transaction History
Sava Infond D.O.O.
- $643 Million
- Q3 2025
A detailed history of Sava Infond D.O.O. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sava Infond D.O.O. holds 3,850 shares of EW stock, worth $332,255. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,850
Previous 5,000
23.0%
Holding current value
$332,255
Previous $391 Million
99.92%
% of portfolio
0.05%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding EW
# of Institutions
1,458Shares Held
468MCall Options Held
3.46MPut Options Held
4.07M-
Vanguard Group Inc Valley Forge, PA70.4MShares$6.07 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...